All news

Hangzhou Daily: visual implant developer Nuanyingjia raises 500 million yuan

Prepared by Sintelligent with the help of SI. Published in SI: . Updated: .

The 500 million yuan raised will go mainly to clinical trials: the retinal product is still in trials, while the 1280-channel visual cortex system remains in development.

Hangzhou-based Hangzhou Nuanyingjia Electronic Technology has closed a 500 million yuan Series C+ round, Hangzhou Daily reported on November 20. It is the second round in 2026: the company has raised 800 million yuan in total. The proceeds will go mainly toward advancing clinical trials of "brain–computer" vision restoration systems. The company is pursuing two lines in parallel. Its 320-channel retinal product is already in clinical trials under GCP standards, with three blind patients implanted. The 1280-channel product for the visual cortex is still in development. In May 2026, a patient who had lost her sight almost 20 years earlier could distinguish the letters H and R the day after implantation of the 320-channel system. Within two months she learned to write Chinese characters and walk along a line.